Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

被引:31
作者
Ahn, Jae-Sook [1 ]
Kim, Hyeoung-Joon [1 ]
Kim, Yeo-Kyeoung [1 ]
Jung, Sung-Hoon [1 ]
Yang, Deok-Hwan [1 ]
Lee, Je-Jung [1 ]
Lee, Il-Kwon [2 ]
Kim, Nan Young [2 ]
Minden, Mark D. [3 ]
Jung, Chul Won [4 ]
Jang, Jun-Ho [4 ]
Kim, Hee Je [5 ]
Moon, Joon Ho [6 ]
Sohn, Sang Kyun [6 ]
Won, Jong-Ho [7 ]
Kim, Sung-Hyun [8 ]
Kim, Namshin [9 ]
Yoshida, Kenichi [10 ]
Ogawa, Seishi [10 ]
Kim, Dennis Dong Hwan [3 ]
机构
[1] Chonnam Natl Univ, Hwasun Hosp, Hematol Oncol, Jeollanam Do, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Jeollanam Do, South Korea
[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON M5S 1A1, Canada
[4] Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea
[5] Catholic Univ Korea, Dept Hematol, Seoul, South Korea
[6] Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea
[7] Soon Chun Hyang Univ Hosp, Dept Hematol Oncol, Seoul, South Korea
[8] Dong A Univ, Coll Med, Dept Hematol Oncol, Busan, South Korea
[9] Korea Res Inst Biosci & Biotechnol, Genome Inst, Epigen Res Ctr, Taejon, South Korea
[10] Kyoto Univ, Kyoto 6068501, Japan
关键词
acute myeloid leukemia; TET2; normal karyotype; homozygous mutation; HEMATOPOIETIC STEM-CELLS; MYELODYSPLASTIC SYNDROMES; DIFFERENTIATION; LEADS; MICE;
D O I
10.3324/haematol.2015.126227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E351 / E353
页数:3
相关论文
共 15 条
[1]   Clinical Effect of Point Mutations in Myelodysplastic Syndromes [J].
Bejar, Rafael ;
Stevenson, Kristen ;
Abdel-Wahab, Omar ;
Galili, Naomi ;
Nilsson, Bjoern ;
Garcia-Manero, Guillermo ;
Kantarjian, Hagop ;
Raza, Azra ;
Levine, Ross L. ;
Neuberg, Donna ;
Ebert, Benjamin L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2496-2506
[2]   TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics [J].
Chou, Wen-Chien ;
Chou, Sheng-Chieh ;
Liu, Chieh-Yu ;
Chen, Chien-Yuan ;
Hou, Hsin-An ;
Kuo, Yuan-Yeh ;
Lee, Ming-Cheng ;
Ko, Bor-Sheng ;
Tang, Jih-Luh ;
Yao, Ming ;
Tsay, Woei ;
Wu, Shang-Ju ;
Huang, Shang-Yi ;
Hsu, Szu-Chun ;
Chen, Yao-Chang ;
Chang, Yi-Chang ;
Kuo, Yi-Yi ;
Kuo, Kuan-Ting ;
Lee, Fen-Yu ;
Liu, Ming-Chi ;
Liu, Chia-Wen ;
Tseng, Mei-Hsuan ;
Huang, Chi-Fei ;
Tien, Hwei-Fang .
BLOOD, 2011, 118 (14) :3803-3810
[3]   Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J].
Doehner, Hartmut ;
Estey, Elihu H. ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Burnett, Alan K. ;
Dombret, Herve ;
Fenaux, Pierre ;
Grimwade, David ;
Larson, Richard A. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel A. ;
Sierra, Jorge ;
Tallman, Martin S. ;
Loewenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2010, 115 (03) :453-474
[4]   Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation [J].
Figueroa, Maria E. ;
Abdel-Wahab, Omar ;
Lu, Chao ;
Ward, Patrick S. ;
Patel, Jay ;
Shih, Alan ;
Li, Yushan ;
Bhagwat, Neha ;
Vasanthakumar, Aparna ;
Fernandez, Hugo F. ;
Tallman, Martin S. ;
Sun, Zhuoxin ;
Wolniak, Kristy ;
Peeters, Justine K. ;
Liu, Wei ;
Choe, Sung E. ;
Fantin, Valeria R. ;
Paietta, Elisabeth ;
Lowenberg, Bob ;
Licht, Jonathan D. ;
Godley, Lucy A. ;
Delwel, Ruud ;
Valk, Peter J. M. ;
Thompson, Craig B. ;
Levine, Ross L. ;
Melnick, An .
CANCER CELL, 2010, 18 (06) :553-567
[5]   TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group [J].
Gaidzik, Verena I. ;
Paschka, Peter ;
Spaeth, Daniela ;
Habdank, Marianne ;
Koehne, Claus-Henning ;
Germing, Ulrich ;
von Lilienfeld-Toal, Marie ;
Held, Gerhard ;
Horst, Heinz-August ;
Haase, Detlef ;
Bentz, Martin ;
Goetze, Katharina ;
Doehner, Hartmut ;
Schlenk, Richard F. ;
Bullinger, Lars ;
Doehner, Konstanze .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) :1350-1357
[6]  
Kim Yeo-Kyeoung, 2010, Korean J Hematol, V45, P36, DOI 10.5045/kjh.2010.45.1.36
[7]   Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice [J].
Ko, Myunggon ;
Bandukwala, Hozefa S. ;
An, Jungeun ;
Lamperti, Edward D. ;
Thompson, Elizabeth C. ;
Hastie, Ryan ;
Tsangaratou, Angeliki ;
Rajewsky, Klaus ;
Koralov, Sergei B. ;
Rao, Anjana .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (35) :14566-14571
[8]   Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 [J].
Ko, Myunggon ;
Huang, Yun ;
Jankowska, Anna M. ;
Pape, Utz J. ;
Tahiliani, Mamta ;
Bandukwala, Hozefa S. ;
An, Jungeun ;
Lamperti, Edward D. ;
Koh, Kian Peng ;
Ganetzky, Rebecca ;
Liu, X. Shirley ;
Aravind, L. ;
Agarwal, Suneet ;
Maciejewski, Jaroslaw P. ;
Rao, Anjana .
NATURE, 2010, 468 (7325) :839-843
[9]   Acquired mutations in TET2 are common in myelodysplastic syndromes [J].
Langemeijer, Saskia M. C. ;
Kuiper, Roland P. ;
Berends, Marieke ;
Knops, Ruth ;
Aslanyan, Mariam G. ;
Massop, Marion ;
Stevens-Linders, Ellen ;
van Hoogen, Patricia ;
van Kessel, Ad Geurts ;
Raymakers, Reinier A. P. ;
Kamping, Eveline J. ;
Verhoef, Gregor E. ;
Verburgh, Estelle ;
Hagemeijer, Anne ;
Vandenberghe, Peter ;
de Witte, Theo ;
van der Reijden, Bert A. ;
Jansen, Joop H. .
NATURE GENETICS, 2009, 41 (07) :838-U102
[10]   Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies [J].
Li, Zhe ;
Cai, Xiaoqiang ;
Cai, Chen-Leng ;
Wang, Jiapeng ;
Zhang, Wenyong ;
Petersen, Bruce E. ;
Yang, Feng-Chun ;
Xu, Mingjiang .
BLOOD, 2011, 118 (17) :4509-4518